Waltham medical device maker NeuroMetrix Inc. said Tuesday that its wearable technology for treatment of chronic pain has received a clearance from the Food and Drug Administration for over-the-counter use.
The device is based on wearable technology that utilizes comfortable, non-invasive electrical stimulation of sensory nerves to induce safe and effective pain relief, the company said in a press release. The technology is presently deployed in the company’s Sensus Pain Management System.
In a statement, NeuroMetrix president and chief executive Shai N. Gozani said: “Patient response to Sensus, our prescription wearable device for treatment of chronic pain, has been very positive since it was launched in early 2013. We believe that there is a substantial consumer market for an over-the-counter version of this technology. The ability to offer both prescription and over-the-counter products will give us maximal market exposure and allow us to reach more people with chronic pain. We anticipate a commercial launch in 2015.”Chris Reidy can be reached at email@example.com.